Member Info for Globetrotter184

Shareholders have been duped and misled. Graham Mullis is a crook and hope he rots in hell.

Well said Brentw1.

NCYT will always be remembered as a company which provided sub standard tests to NHS. Will not stand a chance to share a piece of the cake. Only beneficiaries are the CEO and Directors which are steadily eating into the cash available.

Keep on dreaming Marcin. !!

Admittedly have not been in the chat for quite some time having sold off at a loss but at much higher price. IMO the tox results will be the death knell for Sareum. If SDC 1801 showed any sort of promise it would have long attracted serious interest and possibly a suitor for Sareum. Share Price is slowly disintegrating and holders are simply holding on waiting for the proverbial miracle to happen. For their sake i hope it does happen. Good luck.

Sharebel, what is completely disconnected is not the SP but the total disregard the BOD have for its shareholders. There is no catalyst for the SP and the cash is there to meet the salaries and "other expenses". The company has no direction and even if Monkeypox strain becomes more prevalent there is no guarantee that Novacyt will have any distinct advantage especially with the past history of the PCR tests deemed sub-standard and inedequate.This company is going nowhere. Better opportunity elsewhere.

So many investors here locked in and living in denial and still dreaming of some sort of a windfall which evidently is not going to happen. Unfortunately Investors have been duped. Former Directors including the infamous shameless Mullis who had bumper payouts are the only persons laughing at investors expense. Keep on dreaming guys.!

Right you are CB.

Do not expect any deals from this Trade Conference. Waited for years and will wait a few more it seems.Not dependent on amount invested.Any T/O talk is merely speculative.

Hi Dazzermann, what do you base your price prediction on, if i may ask?

Moniman i would not rush to buy at 30p unless there is a clear strategic plan by the BOD which has shown gross incompetence . There are so many other opportunities in the market in companies which have healthy cash flows and competent BOD.

Hope springs eternal but don't hold your breath WT. Shareholders have been mislead time and time again. The incompetence shown over the last few years is mind boggling. Had been sitting on the sidelines on the basis of a much vaunted favourable outcome from the DHSC dispute.The result is what it is and irreversible.Absolutely no trust in the competence of the BOD . There is no clear catalyst that would prompt new investors . Better value and opportunity elsewhere IMO.

Inevitable dilution. Uncertain outcome of clinical tests.My experience of warrants is that they become worthless. As an LTH i cannot but hold on.I knew the risks and only myself to blame. Ultimately i know my loss which though substantial i can bear. Just another AIM bio company casualty.Nothing new it keeps on happening. I do not believe in miracles.

At these levels there is no other alternative but to hold IMO. It is clearly evident to me that the market knows something we don't know. These are not normal price fluctuations but a true and proper Armageddon.Dilution is now inevitable to keep the company afloat. Having blind faith in the science is not enough.Got to be backed up by hard cash or else Sareum will imply end up as another AIM casualty. Does not look good at all. possibility that company taken over for a pittance .

Good luck Amers. You have guts.

Regretfully potnak, the possibility of missing deadlines is very real with Sareum. The market is sensing this and hence the extreme price weakness. I am still an LTH but i must admit i am losing faith and as you aptly put it i do have my "breaking point". With the SP plummeting i feel as an LTH that i have been left holding the baby. My consolation is that i put in capital i can afford to lose but really i was naive in not taking profits in an AIM share where really there is no protection for investors.

HarChris make an effort not to live in denial and face facts. The price was whipped up to astronomical figures simply as a means for the previous Chairman to cash in and run away. He handed the baby to his successors knowing well enough that there was no strategic growth plan no distribution network. The feud with the DHSC was the proverbial last straw that broke the camels back. Not confident that the case will be won and the weakness in the SP seems to indicate the distinct possibility of this happening following which the possibility of a rights issue is real which would further dilute shareholder value. Not a pretty picture at all. The acquisition of Yourgene and its financial impact on Novacyt in my view remains untested.Can only see the SP drift further south.

Good luck Amers. You certainly need it.

Good luck Amers.

I consider myself as a LTH and generally ignore the wild fluctuations in price which is so common on AIM shares. But for the first time doubts are creeping in my mind as to whether the weakness in the price is " just AIM" or else the expectation of disappointing news. Admittedly the share remain in the high risk category which i accept. But i now feel that the " no news " is " good news" argument is now not a valid argument. Might be and hope i am wrong on this.